apomorphine (apokyn) Report issue

Small molecule Orphan Drug FDA Approved FDA Fast Track FDA Priority Review FDA

Active Ingredient History

NOW
  • Now
Apomorphine, sold under the brand name Apokyn among others, is a type of aporphine having activity as a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Contrary to its name, apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors. The apo- prefix relates to it being a morphine derivative ("[comes] from morphine").   Wikipedia

More Chemistry

Drug Pricing (per unit)

Australia

$14.0608 - $64.4491

United States

$19.5103 - $1031.4200
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

(-)-10,11-dihydroxyaporphine | (−)-10,11-dihydroxyaporphine | (6ar)-6-methyl-5,6,6a,7-tetrahydro-4h-dibenzo[de,g]quinoline-10,11-diol | acetomorphin | acetomorphine | apo-go | apo-go pen | apo-go pfs | apokyn | apomorphin | apomorphine | (-)-apomorphine | apomorphine chloride | apomorphine hcl | apomorphine hydrochloride | apomorphine hydrochloride hemihydrate | apomorphine hydrochloride hydrate | britaject | bromophin | diagesil | diamorph,cocaine,chlorpromazine | diamorph hcl | diamorphine hcl | diamorphine hydrochloride | diamorph roche | diaphine | euphorin | l-apomorphine | (r)-5,6,6a,7-tetrahydro-6-methyl-4h-dibenzo[de,g]quinoline-10,11-diol | r-(-)-apomorphine | r-(−)-apomorphine | uprima

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue